| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC24A5 SLC41A2 CHRNA6 SLC7A1 SLC44A1 PIEZO2 SLC12A1 SLC12A2 HTR3A SLC24A4 SLC22A16 SLC24A2 BEST2 PIEZO1 TTYH2 SLC44A2 KCNK5 SLC24A3 CTNS CNGA4 CHRNB2 CHRNB4 | 8.18e-12 | 1180 | 65 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC24A5 SLC41A2 CHRNA6 PIEZO2 SLC12A1 SLC12A2 HTR3A SLC24A4 SLC24A2 BEST2 PIEZO1 KCNK5 SLC24A3 CTNS CNGA4 CHRNB2 CHRNB4 | 2.56e-11 | 664 | 65 | 17 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC24A5 SLC41A2 CHRNA6 PIEZO2 SLC12A1 SLC12A2 HTR3A SLC24A4 SLC24A2 BEST2 PIEZO1 TTYH2 KCNK5 SLC24A3 CTNS CNGA4 CHRNB2 CHRNB4 | 4.29e-11 | 793 | 65 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | transporter activity | SLC24A5 SLC41A2 CHRNA6 SLC7A1 SLC44A1 PIEZO2 SLC12A1 SLC12A2 HTR3A SLC24A4 SLC22A16 SLC24A2 BEST2 PIEZO1 TTYH2 SLC44A2 KCNK5 SLC24A3 CTNS CNGA4 CHRNB2 CHRNB4 | 4.58e-11 | 1289 | 65 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SLC24A5 CHRNA6 PIEZO2 HTR3A SLC24A4 SLC24A2 BEST2 PIEZO1 KCNK5 SLC24A3 CNGA4 CHRNB2 CHRNB4 | 6.64e-11 | 343 | 65 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | channel activity | SLC24A5 CHRNA6 PIEZO2 SLC12A2 HTR3A SLC24A4 SLC24A2 BEST2 PIEZO1 TTYH2 KCNK5 SLC24A3 CNGA4 CHRNB2 CHRNB4 | 1.01e-10 | 525 | 65 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC24A5 CHRNA6 PIEZO2 SLC12A2 HTR3A SLC24A4 SLC24A2 BEST2 PIEZO1 TTYH2 KCNK5 SLC24A3 CNGA4 CHRNB2 CHRNB4 | 1.03e-10 | 526 | 65 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SLC24A5 CHRNA6 PIEZO2 HTR3A SLC24A4 SLC24A2 BEST2 PIEZO1 TTYH2 KCNK5 SLC24A3 CNGA4 CHRNB2 CHRNB4 | 1.98e-10 | 459 | 65 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 5.10e-10 | 5 | 65 | 4 | GO:0008273 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OPN1MW2 CHRNA6 OPN1MW3 OR13D1 HTR3A TRHR TAS2R36 FZD5 FFAR2 ADGRG1 ROBO1 GPRC5C ADGRV1 OPN1MW TAS2R19 CHRM4 CHRNB2 GPR151 CHRNB4 GPRC5B | 5.41e-09 | 1353 | 65 | 20 | GO:0004888 |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 2.12e-08 | 10 | 65 | 4 | GO:0005432 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 7.15e-08 | 13 | 65 | 4 | GO:0015368 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OPN1MW2 OPN1MW3 OR13D1 TRHR TAS2R36 FZD5 FFAR2 ADGRG1 GPRC5C ADGRV1 OPN1MW TAS2R19 CHRM4 GPR151 GPRC5B | 1.14e-07 | 884 | 65 | 15 | GO:0004930 |
| GeneOntologyMolecularFunction | gated channel activity | CHRNA6 PIEZO2 HTR3A BEST2 PIEZO1 TTYH2 KCNK5 CNGA4 CHRNB2 CHRNB4 | 1.19e-07 | 334 | 65 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 3.82e-07 | 19 | 65 | 4 | GO:0022821 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC24A5 SLC44A1 SLC12A1 SLC12A2 SLC24A4 SLC24A2 SLC44A2 SLC24A3 CTNS | 4.73e-07 | 296 | 65 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | symporter activity | 5.67e-07 | 150 | 65 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 8.64e-07 | 23 | 65 | 4 | GO:0015464 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.17e-06 | 167 | 65 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | amine transmembrane transporter activity | 2.73e-06 | 9 | 65 | 3 | GO:0005275 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.06e-06 | 193 | 65 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.51e-06 | 197 | 65 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.52e-06 | 75 | 65 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC24A5 SLC41A2 SLC12A1 SLC12A2 SLC24A4 SLC24A2 BEST2 TTYH2 KCNK5 SLC24A3 CTNS CNGA4 | 5.20e-06 | 758 | 65 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | antiporter activity | 5.77e-06 | 138 | 65 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.27e-06 | 140 | 65 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | ethanolamine transmembrane transporter activity | 1.04e-05 | 2 | 65 | 2 | GO:0034228 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.15e-05 | 43 | 65 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.15e-05 | 43 | 65 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 1.46e-05 | 15 | 65 | 3 | GO:0008020 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.85e-05 | 100 | 65 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC24A5 SLC41A2 SLC12A1 SLC12A2 SLC24A4 SLC24A2 KCNK5 SLC24A3 CNGA4 | 1.87e-05 | 465 | 65 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.96e-05 | 171 | 65 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | photoreceptor activity | 2.17e-05 | 17 | 65 | 3 | GO:0009881 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 2.17e-05 | 17 | 65 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC24A5 SLC44A1 SLC12A1 SLC12A2 SLC24A4 SLC24A2 SLC44A2 SLC24A3 CTNS | 2.29e-05 | 477 | 65 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | potassium:sodium symporter activity | 3.12e-05 | 3 | 65 | 2 | GO:0009674 | |
| GeneOntologyMolecularFunction | sodium:potassium:chloride symporter activity | 3.12e-05 | 3 | 65 | 2 | GO:0008511 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC24A5 SLC41A2 SLC12A1 SLC12A2 SLC24A4 SLC24A2 KCNK5 SLC24A3 CTNS CNGA4 | 3.27e-05 | 627 | 65 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.55e-05 | 57 | 65 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.35e-05 | 60 | 65 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 5.43e-05 | 301 | 65 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.96e-05 | 65 | 65 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.96e-05 | 65 | 65 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.30e-05 | 129 | 65 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.16e-04 | 77 | 65 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.33e-04 | 151 | 65 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.55e-04 | 83 | 65 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | alcohol transmembrane transporter activity | 2.88e-04 | 8 | 65 | 2 | GO:0015665 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 2.88e-04 | 8 | 65 | 2 | GO:0015220 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 3.70e-04 | 9 | 65 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | structural constituent of myelin sheath | 5.63e-04 | 11 | 65 | 2 | GO:0019911 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine phosphatase activity | 6.74e-04 | 12 | 65 | 2 | GO:0004726 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 7.38e-04 | 125 | 65 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 7.95e-04 | 13 | 65 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.37e-03 | 17 | 65 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.49e-03 | 151 | 65 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.54e-03 | 18 | 65 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 1.72e-03 | 19 | 65 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.34e-03 | 171 | 65 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.53e-03 | 23 | 65 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.22e-03 | 26 | 65 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 3.47e-03 | 27 | 65 | 2 | GO:0033038 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 5.16e-03 | 33 | 65 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.16e-03 | 33 | 65 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | taste receptor activity | 5.16e-03 | 33 | 65 | 2 | GO:0008527 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.89e-03 | 119 | 65 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.16e-02 | 50 | 65 | 2 | GO:0099095 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC24A5 SLC41A2 CHRNA6 PLLP PIEZO2 SLC12A1 SLC12A2 HTR3A SLC24A4 SLC22A16 SLC24A2 DSPP BEST2 PIEZO1 TTYH2 KCNK5 SLC24A3 PTPN22 CTNS CNGA4 CLEC4C CHRNB2 CHRNB4 | 1.10e-11 | 1374 | 65 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC24A5 SLC41A2 CHRNA6 PLLP PIEZO2 SLC12A1 SLC12A2 HTR3A SLC24A4 SLC24A2 BEST2 PIEZO1 TTYH2 KCNK5 SLC24A3 PTPN22 CTNS CNGA4 CLEC4C CHRNB2 CHRNB4 | 1.27e-11 | 1115 | 65 | 21 | GO:0034220 |
| GeneOntologyBiologicalProcess | detection of external stimulus | OPN1MW2 OPN1MW3 PIEZO2 SLC12A2 SLC24A4 PIEZO1 PRPH2 ADGRV1 OPN1MW | 3.56e-09 | 173 | 65 | 9 | GO:0009581 |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | OPN1MW2 OPN1MW3 PIEZO2 SLC12A2 SLC24A4 PIEZO1 PRPH2 ADGRV1 OPN1MW | 3.94e-09 | 175 | 65 | 9 | GO:0009582 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC24A5 SLC41A2 PIEZO2 SLC12A1 SLC12A2 SLC24A4 SLC24A2 DSPP BEST2 PIEZO1 KCNK5 SLC24A3 PTPN22 CTNS CNGA4 CLEC4C CHRNB2 | 6.91e-08 | 1157 | 65 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC24A5 SLC41A2 PIEZO2 SLC12A1 SLC12A2 SLC24A4 SLC24A2 BEST2 PIEZO1 KCNK5 SLC24A3 PTPN22 CTNS CNGA4 CLEC4C | 1.71e-07 | 942 | 65 | 15 | GO:0098655 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OPN1MW2 OPN1MW3 OR13D1 SLC24A4 TRHR TAS2R36 FZD5 FFAR2 ADGRG1 ROBO1 GPRC5C ADGRV1 OPN1MW TAS2R19 LMBRD2 CHRM4 GPR151 GPRC5B | 1.84e-07 | 1395 | 65 | 18 | GO:0007186 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC24A5 SLC41A2 SLC12A1 SLC12A2 HTR3A SLC24A4 SLC24A2 BEST2 TTYH2 KCNK5 SLC24A3 PTPN22 CTNS CNGA4 CLEC4C | 4.56e-07 | 1017 | 65 | 15 | GO:0098660 |
| GeneOntologyBiologicalProcess | sensory perception | OPN1MW2 OPN1MW3 PIEZO2 OR13D1 SLC12A2 SLC24A4 TAS2R36 BEST2 PRPH2 GPRC5C ADGRV1 OPN1MW TAS2R19 CNGA4 CHRNB2 | 8.86e-07 | 1072 | 65 | 15 | GO:0007600 |
| GeneOntologyBiologicalProcess | potassium ion transport | 2.17e-06 | 272 | 65 | 8 | GO:0006813 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OPN1MW2 OPN1MW3 PIEZO2 OR13D1 SLC12A2 SLC24A4 TAS2R36 PIEZO1 PRPH2 ADGRV1 OPN1MW TAS2R19 | 2.27e-06 | 722 | 65 | 12 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of light stimulus | 4.41e-06 | 77 | 65 | 5 | GO:0009583 | |
| GeneOntologyBiologicalProcess | amine transport | 4.61e-06 | 137 | 65 | 6 | GO:0015837 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC24A5 SLC41A2 SLC12A1 SLC12A2 HTR3A SLC24A4 SLC24A2 KCNK5 SLC24A3 PTPN22 CTNS CNGA4 CLEC4C | 4.95e-06 | 922 | 65 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | visual perception | 7.86e-06 | 230 | 65 | 7 | GO:0007601 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 8.32e-06 | 232 | 65 | 7 | GO:0071805 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 8.56e-06 | 233 | 65 | 7 | GO:0050953 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CHRNA6 PIEZO2 HTR3A SLC24A4 BEST2 PIEZO1 KCNK5 CTNS CHRNB2 CHRNB4 | 9.25e-06 | 559 | 65 | 10 | GO:0042391 |
| GeneOntologyBiologicalProcess | ethanolamine transport | 9.78e-06 | 2 | 65 | 2 | GO:0034229 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC24A5 SLC41A2 SLC12A1 SLC12A2 SLC24A4 SLC24A2 DSPP KCNK5 SLC24A3 PTPN22 CNGA4 CLEC4C CHRNB2 | 1.19e-05 | 1000 | 65 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 2.01e-05 | 51 | 65 | 4 | GO:0095500 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 2.34e-05 | 53 | 65 | 4 | GO:1905145 | |
| GeneOntologyBiologicalProcess | phototransduction | 2.34e-05 | 53 | 65 | 4 | GO:0007602 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.50e-05 | 275 | 65 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 2.92e-05 | 56 | 65 | 4 | GO:1905144 | |
| GeneOntologyBiologicalProcess | synaptic transmission involved in micturition | 2.93e-05 | 3 | 65 | 2 | GO:0060084 | |
| GeneOntologyBiologicalProcess | calcium ion transport | SLC24A5 SLC24A4 SLC24A2 DSPP SLC24A3 PTPN22 CNGA4 CLEC4C CHRNB2 | 2.96e-05 | 509 | 65 | 9 | GO:0006816 |
| GeneOntologyBiologicalProcess | detection of visible light | 3.13e-05 | 57 | 65 | 4 | GO:0009584 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 4.92e-05 | 208 | 65 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 6.66e-05 | 69 | 65 | 4 | GO:0098926 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 8.54e-05 | 142 | 65 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 8.54e-05 | 142 | 65 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 8.59e-05 | 230 | 65 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 9.23e-05 | 75 | 65 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.64e-04 | 87 | 65 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.72e-04 | 88 | 65 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | response to light stimulus | 1.96e-04 | 382 | 65 | 7 | GO:0009416 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 2.29e-04 | 392 | 65 | 7 | GO:0070588 | |
| GeneOntologyBiologicalProcess | calcium ion import | 2.60e-04 | 98 | 65 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 3.14e-04 | 42 | 65 | 3 | GO:0006884 | |
| GeneOntologyBiologicalProcess | mammary duct terminal end bud growth | 3.47e-04 | 9 | 65 | 2 | GO:0060763 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 3.61e-04 | 44 | 65 | 3 | GO:0007271 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 4.32e-04 | 112 | 65 | 4 | GO:1902476 | |
| GeneOntologyBiologicalProcess | choline transport | 4.33e-04 | 10 | 65 | 2 | GO:0015871 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 4.70e-04 | 582 | 65 | 8 | GO:0050906 | |
| GeneOntologyBiologicalProcess | micturition | 5.28e-04 | 11 | 65 | 2 | GO:0060073 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 5.28e-04 | 11 | 65 | 2 | GO:0035095 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 5.58e-04 | 51 | 65 | 3 | GO:1990573 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 5.79e-04 | 121 | 65 | 4 | GO:0051899 | |
| GeneOntologyBiologicalProcess | chloride transport | 7.15e-04 | 128 | 65 | 4 | GO:0006821 | |
| GeneOntologyBiologicalProcess | cellular response to light stimulus | 7.58e-04 | 130 | 65 | 4 | GO:0071482 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 7.58e-04 | 130 | 65 | 4 | GO:0060079 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 7.74e-04 | 57 | 65 | 3 | GO:0050974 | |
| GeneOntologyBiologicalProcess | response to nicotine | 8.14e-04 | 58 | 65 | 3 | GO:0035094 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 8.48e-04 | 134 | 65 | 4 | GO:0098661 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | OPN1MW2 OPN1MW3 PIEZO2 SLC12A2 SLC24A4 PIEZO1 PRPH2 CTNS ADGRV1 OPN1MW CHRNB2 GPR151 | 9.99e-04 | 1361 | 65 | 12 | GO:0009628 |
| GeneOntologyBiologicalProcess | response to radiation | 1.01e-03 | 503 | 65 | 7 | GO:0009314 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 1.10e-03 | 371 | 65 | 6 | GO:0071214 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 1.10e-03 | 371 | 65 | 6 | GO:0104004 | |
| GeneOntologyBiologicalProcess | organic cation transport | 1.14e-03 | 145 | 65 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | regulation of secondary metabolite biosynthetic process | 1.14e-03 | 16 | 65 | 2 | GO:1900376 | |
| GeneOntologyBiologicalProcess | regulation of melanin biosynthetic process | 1.14e-03 | 16 | 65 | 2 | GO:0048021 | |
| GeneOntologyBiologicalProcess | regulation of secondary metabolic process | 1.14e-03 | 16 | 65 | 2 | GO:0043455 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.20e-03 | 147 | 65 | 4 | GO:0099565 | |
| GeneOntologyBiologicalProcess | response to light intensity | 1.29e-03 | 17 | 65 | 2 | GO:0009642 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.39e-03 | 153 | 65 | 4 | GO:0098656 | |
| GeneOntologyBiologicalProcess | positive regulation of production of molecular mediator of immune response | 1.56e-03 | 158 | 65 | 4 | GO:0002702 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.09e-06 | 196 | 67 | 7 | GO:0097730 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 5.55e-06 | 139 | 67 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 9.62e-06 | 153 | 67 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 2.48e-05 | 18 | 67 | 3 | GO:0005892 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.73e-05 | 378 | 67 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 2.86e-05 | 111 | 67 | 5 | GO:0001750 | |
| GeneOntologyCellularComponent | cholinergic synapse | 4.64e-05 | 22 | 67 | 3 | GO:0098981 | |
| GeneOntologyCellularComponent | photoreceptor disc membrane | 7.76e-05 | 26 | 67 | 3 | GO:0097381 | |
| GeneOntologyCellularComponent | cilium | OPN1MW2 ADGB OPN1MW3 SLC24A4 BEST2 PRPH2 ADGRV1 OPN1MW TAS2R19 DNAH5 CNGA4 | 1.23e-04 | 898 | 67 | 11 | GO:0005929 |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.60e-04 | 523 | 67 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.60e-04 | 277 | 67 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | transporter complex | 3.64e-04 | 550 | 67 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.88e-03 | 405 | 67 | 6 | GO:0045211 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 2.02e-03 | 78 | 67 | 3 | GO:0001917 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 2.24e-03 | 22 | 67 | 2 | GO:0098691 | |
| GeneOntologyCellularComponent | receptor complex | 2.54e-03 | 581 | 67 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.59e-03 | 583 | 67 | 7 | GO:0097060 | |
| HumanPheno | Abnormal foveal morphology on macular OCT | 6.50e-06 | 8 | 26 | 3 | HP:0030613 | |
| MousePheno | abnormal vision | 2.11e-05 | 89 | 53 | 5 | MP:0002090 | |
| MousePheno | enhanced neuronal migration | 4.22e-05 | 3 | 53 | 2 | MP:0014552 | |
| MousePheno | abnormal odor adaptation | 8.42e-05 | 4 | 53 | 2 | MP:0009562 | |
| Domain | K/Na/Ca-exchanger | 6.25e-10 | 5 | 64 | 4 | IPR004481 | |
| Domain | NaCa_Exmemb | 1.56e-08 | 9 | 64 | 4 | IPR004837 | |
| Domain | Na_Ca_ex | 1.56e-08 | 9 | 64 | 4 | PF01699 | |
| Domain | Acetylcholine_rcpt_TM | 1.06e-06 | 23 | 64 | 4 | IPR027361 | |
| Domain | - | 1.06e-06 | 23 | 64 | 4 | 1.20.120.370 | |
| Domain | Piezo | 1.16e-05 | 2 | 64 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 1.16e-05 | 2 | 64 | 2 | PF12166 | |
| Domain | Piezo_dom | 1.16e-05 | 2 | 64 | 2 | IPR031805 | |
| Domain | PIEZO | 1.16e-05 | 2 | 64 | 2 | PF15917 | |
| Domain | Piezo_RRas-bd_dom | 1.16e-05 | 2 | 64 | 2 | IPR031334 | |
| Domain | Na/K/Cl_cotranspt | 1.16e-05 | 2 | 64 | 2 | IPR002443 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.68e-05 | 45 | 64 | 4 | IPR018000 | |
| Domain | Neur_chan_memb | 1.84e-05 | 46 | 64 | 4 | PF02932 | |
| Domain | Neur_chan_LBD | 2.00e-05 | 47 | 64 | 4 | PF02931 | |
| Domain | Neur_channel | 2.00e-05 | 47 | 64 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.00e-05 | 47 | 64 | 4 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 2.00e-05 | 47 | 64 | 4 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 2.00e-05 | 47 | 64 | 4 | IPR006029 | |
| Domain | - | 2.00e-05 | 47 | 64 | 4 | 2.70.170.10 | |
| Domain | Nicotinic_acetylcholine_rcpt | 2.08e-05 | 16 | 64 | 3 | IPR002394 | |
| Domain | Opsin_red/grn | 3.46e-05 | 3 | 64 | 2 | IPR000378 | |
| Domain | AA_permease_N | 3.46e-05 | 3 | 64 | 2 | IPR013612 | |
| Domain | AA_permease_N | 3.46e-05 | 3 | 64 | 2 | PF08403 | |
| Domain | AA-permease/SLC12A_dom | 5.64e-05 | 22 | 64 | 3 | IPR004841 | |
| Domain | AA_permease | 5.64e-05 | 22 | 64 | 3 | PF00324 | |
| Domain | Choline_transpo | 1.15e-04 | 5 | 64 | 2 | PF04515 | |
| Domain | MAL | 1.15e-04 | 5 | 64 | 2 | IPR013295 | |
| Domain | Choline_transptr-like | 1.15e-04 | 5 | 64 | 2 | IPR007603 | |
| Domain | SLC12A_fam | 2.40e-04 | 7 | 64 | 2 | IPR004842 | |
| Domain | SLC12 | 3.19e-04 | 8 | 64 | 2 | PF03522 | |
| Domain | SLC12_C | 3.19e-04 | 8 | 64 | 2 | IPR018491 | |
| Domain | OPSIN | 5.11e-04 | 10 | 64 | 2 | PS00238 | |
| Domain | AdipoR/HlyIII-related | 6.23e-04 | 11 | 64 | 2 | IPR004254 | |
| Domain | Opsin | 6.23e-04 | 11 | 64 | 2 | IPR001760 | |
| Domain | HlyIII | 6.23e-04 | 11 | 64 | 2 | PF03006 | |
| Domain | GPCR_2-like | 1.14e-03 | 60 | 64 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.20e-03 | 61 | 64 | 3 | PS50261 | |
| Domain | GPCR_3 | 2.33e-03 | 21 | 64 | 2 | IPR000337 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 2.55e-03 | 22 | 64 | 2 | PS50259 | |
| Domain | 7tm_3 | 2.55e-03 | 22 | 64 | 2 | PF00003 | |
| Domain | GPCR_3_C | 2.55e-03 | 22 | 64 | 2 | IPR017978 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 2.55e-03 | 22 | 64 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 2.55e-03 | 22 | 64 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 2.55e-03 | 22 | 64 | 2 | PS00979 | |
| Domain | MARVEL | 3.84e-03 | 27 | 64 | 2 | PF01284 | |
| Domain | MARVEL | 4.13e-03 | 28 | 64 | 2 | PS51225 | |
| Domain | Marvel | 4.13e-03 | 28 | 64 | 2 | IPR008253 | |
| Domain | GPS | 6.04e-03 | 34 | 64 | 2 | SM00303 | |
| Domain | GPS | 6.39e-03 | 35 | 64 | 2 | PF01825 | |
| Domain | 7TM_GPCR_Srsx | 6.71e-03 | 112 | 64 | 3 | SM01381 | |
| Domain | GPS | 6.76e-03 | 36 | 64 | 2 | PS50221 | |
| Domain | PTPc | 6.76e-03 | 36 | 64 | 2 | SM00194 | |
| Domain | GPS | 7.13e-03 | 37 | 64 | 2 | IPR000203 | |
| Domain | GPCR_Rhodpsn_7TM | 7.83e-03 | 670 | 64 | 7 | IPR017452 | |
| Domain | TYR_PHOSPHATASE_PTP | 7.89e-03 | 39 | 64 | 2 | PS50055 | |
| Domain | 7tm_1 | 8.26e-03 | 677 | 64 | 7 | PF00001 | |
| Domain | PTPase_domain | 8.70e-03 | 41 | 64 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 8.70e-03 | 41 | 64 | 2 | PF00102 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 8.79e-03 | 685 | 64 | 7 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 9.19e-03 | 691 | 64 | 7 | PS50262 | |
| Domain | GPCR_Rhodpsn | 9.26e-03 | 692 | 64 | 7 | IPR000276 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC24A5 SLC41A2 SLC7A1 SLC44A1 SLC12A1 SLC12A2 SLC24A4 SLC22A16 SLC24A2 SLC44A2 SLC24A3 CTNS | 1.26e-11 | 238 | 47 | 12 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC24A5 SLC41A2 SLC7A1 SLC44A1 SLC12A1 SLC12A2 SLC24A4 SLC22A16 SLC24A2 SLC44A2 SLC24A3 CTNS | 2.14e-11 | 249 | 47 | 12 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.24e-09 | 108 | 47 | 8 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.41e-09 | 109 | 47 | 8 | MM15074 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC24A5 SLC41A2 SLC7A1 SLC44A1 SLC12A1 SLC12A2 SLC24A4 DERL1 SLC22A16 SLC24A2 BEST2 TTYH2 SLC44A2 SLC24A3 CTNS | 2.77e-09 | 681 | 47 | 15 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC24A5 SLC41A2 SLC7A1 SLC44A1 SLC12A1 SLC12A2 SLC24A4 DERL1 SLC22A16 SLC24A2 BEST2 TTYH2 SLC44A2 SLC24A3 CTNS | 7.96e-09 | 736 | 47 | 15 | M27287 |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 3.52e-08 | 11 | 47 | 4 | M27336 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 7.58e-08 | 13 | 47 | 4 | MM15078 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.88e-06 | 9 | 47 | 3 | MM15313 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.88e-06 | 9 | 47 | 3 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 5.63e-06 | 11 | 47 | 3 | M883 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.48e-06 | 12 | 47 | 3 | MM15312 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.48e-06 | 12 | 47 | 3 | M48008 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.23e-05 | 14 | 47 | 3 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.54e-05 | 15 | 47 | 3 | MM14704 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.17e-04 | 76 | 47 | 4 | MM15072 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.72e-04 | 84 | 47 | 4 | M27334 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 2.26e-04 | 7 | 47 | 2 | MM15311 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.26e-04 | 7 | 47 | 2 | M27339 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 2.26e-04 | 7 | 47 | 2 | M27596 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.26e-04 | 7 | 47 | 2 | MM15081 | |
| Pathway | WP_GPCRS_NONODORANT | 2.39e-04 | 266 | 47 | 6 | MM15843 | |
| Pathway | REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION | 3.01e-04 | 8 | 47 | 2 | MM14880 | |
| Pathway | REACTOME_OPSINS | 4.81e-04 | 10 | 47 | 2 | MM15063 | |
| Pathway | KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS | 7.24e-04 | 53 | 47 | 3 | M3812 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.11e-03 | 15 | 47 | 2 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.11e-03 | 15 | 47 | 2 | MM15845 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.32e-03 | 144 | 47 | 4 | MM14501 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 1.79e-03 | 19 | 47 | 2 | M47793 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 2.04e-03 | 272 | 47 | 5 | M13380 | |
| Pathway | WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS | 2.19e-03 | 21 | 47 | 2 | M39343 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 2.81e-03 | 177 | 47 | 4 | M27476 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.90e-03 | 430 | 47 | 6 | MM15160 | |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 3.36e-03 | 26 | 47 | 2 | MM14584 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.36e-03 | 186 | 47 | 4 | MM15994 | |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 3.89e-03 | 28 | 47 | 2 | M684 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 4.17e-03 | 463 | 47 | 6 | M507 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 4.36e-03 | 99 | 47 | 3 | M27474 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.75e-03 | 205 | 47 | 4 | M752 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 4.86e-03 | 333 | 47 | 5 | MM14963 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.26e-03 | 211 | 47 | 4 | MM14502 | |
| Pubmed | Expression of potassium-dependent sodium-calcium exchanger in the murine lens. | 6.67e-11 | 5 | 68 | 4 | 29128492 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 27093457 | ||
| Pubmed | Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy. | 2.86e-08 | 4 | 68 | 3 | 29386880 | |
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 26631410 | ||
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 5.07e-08 | 19 | 68 | 4 | 17373692 | |
| Pubmed | Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. | 7.13e-08 | 5 | 68 | 3 | 2937147 | |
| Pubmed | Peripherin-2 differentially interacts with cone opsins in outer segments of cone photoreceptors. | 7.13e-08 | 5 | 68 | 3 | 27033727 | |
| Pubmed | Functional interaction between Lypd6 and nicotinic acetylcholine receptors. | 3.98e-07 | 8 | 68 | 3 | 27344019 | |
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 8906617 | ||
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 19228980 | ||
| Pubmed | 8.49e-07 | 10 | 68 | 3 | 20736995 | ||
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 12225896 | ||
| Pubmed | Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. | 1.17e-06 | 11 | 68 | 3 | 29791835 | |
| Pubmed | 2.56e-06 | 14 | 68 | 3 | 19059502 | ||
| Pubmed | 2.56e-06 | 14 | 68 | 3 | 30924851 | ||
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 3.20e-06 | 15 | 68 | 3 | 8838678 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 3.63e-06 | 118 | 68 | 5 | 19156168 | |
| Pubmed | Calcium signaling induces partial EMT and renal fibrosis in a Wnt4mCherry knock-in mouse model. | 3.64e-06 | 53 | 68 | 4 | 38653356 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30324494 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15537871 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 28402104 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 9672238 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 27129268 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 33789160 | ||
| Pubmed | Characterization of choline transporters in the human placenta over gestation. | 3.77e-06 | 2 | 68 | 2 | 26601765 | |
| Pubmed | [Feeling the pressure? Identification of two proteins activated by mechanical forces]. | 3.77e-06 | 2 | 68 | 2 | 21299953 | |
| Pubmed | Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum. | 3.77e-06 | 2 | 68 | 2 | 12150770 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21768117 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21056836 | ||
| Pubmed | Defective colour vision associated with a missense mutation in the human green visual pigment gene. | 3.77e-06 | 2 | 68 | 2 | 1302020 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30745454 | ||
| Pubmed | The role of PIEZO ion channels in the musculoskeletal system. | 3.77e-06 | 2 | 68 | 2 | 36717101 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10531434 | ||
| Pubmed | Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development. | 3.77e-06 | 2 | 68 | 2 | 38395992 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16814616 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 37820892 | ||
| Pubmed | Astrocytes in the optic nerve head express putative mechanosensitive channels. | 3.77e-06 | 2 | 68 | 2 | 26236150 | |
| Pubmed | Touch, Tension, and Transduction - The Function and Regulation of Piezo Ion Channels. | 3.77e-06 | 2 | 68 | 2 | 27743844 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 33672580 | ||
| Pubmed | Axonal and Glial PIEZO1 and PIEZO2 Immunoreactivity in Human Clitoral Krause's Corpuscles. | 3.77e-06 | 2 | 68 | 2 | 38928429 | |
| Pubmed | Mechanisms of mechanotransduction and physiological roles of PIEZO channels. | 3.77e-06 | 2 | 68 | 2 | 39251883 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30628892 | ||
| Pubmed | Piezo1 ion channel pore properties are dictated by C-terminal region. | 3.77e-06 | 2 | 68 | 2 | 26008989 | |
| Pubmed | Native α6β4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland. | 3.77e-06 | 2 | 68 | 2 | 21917987 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 22241831 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 37975162 | ||
| Pubmed | Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. | 3.77e-06 | 2 | 68 | 2 | 20813920 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10319869 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 7929272 | ||
| Pubmed | Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels. | 3.77e-06 | 2 | 68 | 2 | 28636944 | |
| Pubmed | A Plug-and-Latch Mechanism for Gating the Mechanosensitive Piezo Channel. | 3.77e-06 | 2 | 68 | 2 | 32142647 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21840300 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 34464353 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24085295 | ||
| Pubmed | Increased Slc12a1 expression in β-cells and improved glucose disposal in Slc12a2 heterozygous mice. | 3.77e-06 | 2 | 68 | 2 | 26400961 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 20410607 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 8640224 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 25037583 | ||
| Pubmed | α6β2 nicotinic acetylcholine receptors influence locomotor activity and ethanol consumption. | 3.77e-06 | 2 | 68 | 2 | 28457669 | |
| Pubmed | 3.93e-06 | 16 | 68 | 3 | 27328943 | ||
| Pubmed | 3.93e-06 | 16 | 68 | 3 | 19259974 | ||
| Pubmed | MafB-dependent neurotransmitter signaling promotes β cell migration in the developing pancreas. | 4.77e-06 | 17 | 68 | 3 | 36897571 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 38124148 | ||
| Pubmed | Molecular determinants of human red/green color discrimination. | 1.13e-05 | 3 | 68 | 2 | 8185948 | |
| Pubmed | X-linked cone dystrophy caused by mutation of the red and green cone opsins. | 1.13e-05 | 3 | 68 | 2 | 20579627 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 38410159 | ||
| Pubmed | Chloride-dependent spectral tuning mechanism of L-group cone visual pigments. | 1.13e-05 | 3 | 68 | 2 | 23350963 | |
| Pubmed | Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance. | 1.13e-05 | 3 | 68 | 2 | 20471354 | |
| Pubmed | Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling. | 1.13e-05 | 3 | 68 | 2 | 24647947 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 25068303 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 10945465 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 16407231 | ||
| Pubmed | Multiple hypothalamic cell populations encoding distinct visual information. | 1.13e-05 | 3 | 68 | 2 | 21224225 | |
| Pubmed | Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy. | 1.13e-05 | 3 | 68 | 2 | 28751656 | |
| Pubmed | Nicotinic acetylcholine receptors in the autonomic control of bladder function. | 1.13e-05 | 3 | 68 | 2 | 10771006 | |
| Pubmed | Circadian Regulation of the Rod Contribution to Mesopic Vision in Mice. | 1.13e-05 | 3 | 68 | 2 | 36216501 | |
| Pubmed | Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy. | 1.13e-05 | 3 | 68 | 2 | 31469404 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 29521261 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 20923852 | ||
| Pubmed | The molecular genetics and evolution of red and green color vision in vertebrates. | 1.13e-05 | 3 | 68 | 2 | 11545071 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12944511 | ||
| Pubmed | Mechanisms of spectral tuning in the mouse green cone pigment. | 1.13e-05 | 3 | 68 | 2 | 9238068 | |
| Pubmed | PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex. | 1.13e-05 | 3 | 68 | 2 | 30361375 | |
| Pubmed | Piezo1, a mechanically activated ion channel, is required for vascular development in mice. | 1.13e-05 | 3 | 68 | 2 | 24958852 | |
| Pubmed | Emergence of novel color vision in mice engineered to express a human cone photopigment. | 1.13e-05 | 3 | 68 | 2 | 17379811 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 15694199 | ||
| Pubmed | Spectral tuning of a circadian photopigment in a subterranean 'blind' mammal (Spalax ehrenbergi). | 1.13e-05 | 3 | 68 | 2 | 10567724 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 10783259 | ||
| Pubmed | The G protein-coupled receptor GPRC5B contributes to neurogenesis in the developing mouse neocortex. | 1.13e-05 | 3 | 68 | 2 | 24089469 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 8663127 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 37321223 | ||
| Pubmed | The Na+/Ca2+, K+ exchanger NCKX4 is required for efficient cone-mediated vision. | 1.13e-05 | 3 | 68 | 2 | 28650316 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 34111401 | ||
| Pubmed | Co-expression of murine opsins facilitates identifying the site of cone adaptation. | 1.13e-05 | 3 | 68 | 2 | 12511072 | |
| Pubmed | Nicotine stimulates ion transport via metabotropic β4 subunit containing nicotinic ACh receptors. | 1.13e-05 | 3 | 68 | 2 | 32959891 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 26746385 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 30891952 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 11027228 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 7958444 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 30726728 | ||
| Interaction | STUM interactions | 4.67e-07 | 21 | 62 | 4 | int:STUM | |
| Interaction | YIPF6 interactions | 1.59e-06 | 117 | 62 | 6 | int:YIPF6 | |
| Interaction | TMEM186 interactions | 2.26e-06 | 69 | 62 | 5 | int:TMEM186 | |
| Interaction | C5AR1 interactions | 7.80e-06 | 154 | 62 | 6 | int:C5AR1 | |
| Interaction | GJC1 interactions | 8.33e-06 | 42 | 62 | 4 | int:GJC1 | |
| Interaction | CERS6 interactions | 1.70e-05 | 104 | 62 | 5 | int:CERS6 | |
| Interaction | BSCL2 interactions | 2.28e-05 | 186 | 62 | 6 | int:BSCL2 | |
| Interaction | PNLIPRP1 interactions | 2.46e-05 | 55 | 62 | 4 | int:PNLIPRP1 | |
| Interaction | CHRNA2 interactions | 2.79e-05 | 3 | 62 | 2 | int:CHRNA2 | |
| Interaction | GJB2 interactions | 5.71e-05 | 68 | 62 | 4 | int:GJB2 | |
| Interaction | FPR2 interactions | 6.62e-05 | 138 | 62 | 5 | int:FPR2 | |
| Interaction | SPPL2B interactions | 8.02e-05 | 233 | 62 | 6 | int:SPPL2B | |
| Interaction | ERGIC3 interactions | 8.11e-05 | 340 | 62 | 7 | int:ERGIC3 | |
| Interaction | MTX3 interactions | 8.83e-05 | 76 | 62 | 4 | int:MTX3 | |
| Interaction | ERMP1 interactions | 8.93e-05 | 147 | 62 | 5 | int:ERMP1 | |
| Interaction | CMTM5 interactions | 9.22e-05 | 239 | 62 | 6 | int:CMTM5 | |
| Interaction | OCA2 interactions | 9.26e-05 | 5 | 62 | 2 | int:OCA2 | |
| Interaction | RHBDD3 interactions | 9.57e-05 | 29 | 62 | 3 | int:RHBDD3 | |
| Interaction | TMEM218 interactions | 1.03e-04 | 79 | 62 | 4 | int:TMEM218 | |
| Interaction | UBXN8 interactions | 1.08e-04 | 80 | 62 | 4 | int:UBXN8 | |
| Interaction | CHRNA4 interactions | 1.29e-04 | 159 | 62 | 5 | int:CHRNA4 | |
| Interaction | LRRC8A interactions | 1.36e-04 | 85 | 62 | 4 | int:LRRC8A | |
| Interaction | GRAMD1A interactions | 1.67e-04 | 168 | 62 | 5 | int:GRAMD1A | |
| Interaction | TMEM128 interactions | 1.70e-04 | 90 | 62 | 4 | int:TMEM128 | |
| Interaction | FAM241B interactions | 1.70e-04 | 90 | 62 | 4 | int:FAM241B | |
| Interaction | TSPAN15 interactions | 2.02e-04 | 276 | 62 | 6 | int:TSPAN15 | |
| Interaction | C1QL1 interactions | 2.17e-04 | 38 | 62 | 3 | int:C1QL1 | |
| Interaction | CHRNA3 interactions | 2.34e-04 | 39 | 62 | 3 | int:CHRNA3 | |
| Interaction | GPRC5C interactions | 2.86e-04 | 103 | 62 | 4 | int:GPRC5C | |
| Interaction | DPY19L4 interactions | 3.13e-04 | 43 | 62 | 3 | int:DPY19L4 | |
| Interaction | TTYH1 interactions | 3.16e-04 | 300 | 62 | 6 | int:TTYH1 | |
| Interaction | VIPR2 interactions | 3.26e-04 | 194 | 62 | 5 | int:VIPR2 | |
| Interaction | C6orf89 interactions | 3.31e-04 | 9 | 62 | 2 | int:C6orf89 | |
| Interaction | TRARG1 interactions | 3.80e-04 | 111 | 62 | 4 | int:TRARG1 | |
| Interaction | STRIT1 interactions | 4.35e-04 | 48 | 62 | 3 | int:STRIT1 | |
| Interaction | GPR89A interactions | 5.11e-04 | 120 | 62 | 4 | int:GPR89A | |
| Interaction | PTAFR interactions | 5.20e-04 | 51 | 62 | 3 | int:PTAFR | |
| Interaction | SLC29A1 interactions | 5.27e-04 | 121 | 62 | 4 | int:SLC29A1 | |
| Interaction | GPR151 interactions | 5.82e-04 | 53 | 62 | 3 | int:GPR151 | |
| Interaction | CYB5R1 interactions | 6.33e-04 | 127 | 62 | 4 | int:CYB5R1 | |
| Interaction | CHRNA5 interactions | 6.49e-04 | 55 | 62 | 3 | int:CHRNA5 | |
| Interaction | ELOVL4 interactions | 6.51e-04 | 128 | 62 | 4 | int:ELOVL4 | |
| Interaction | IGFBP5 interactions | 6.71e-04 | 129 | 62 | 4 | int:IGFBP5 | |
| Interaction | CNNM1 interactions | 6.84e-04 | 56 | 62 | 3 | int:CNNM1 | |
| Interaction | FFAR1 interactions | 7.78e-04 | 235 | 62 | 5 | int:FFAR1 | |
| Interaction | MFSD8 interactions | 7.97e-04 | 59 | 62 | 3 | int:MFSD8 | |
| Interaction | ORMDL3 interactions | 8.37e-04 | 60 | 62 | 3 | int:ORMDL3 | |
| Interaction | SHISAL1 interactions | 8.37e-04 | 60 | 62 | 3 | int:SHISAL1 | |
| Interaction | POMT2 interactions | 8.37e-04 | 60 | 62 | 3 | int:POMT2 | |
| Interaction | ATP6V0C interactions | 8.40e-04 | 137 | 62 | 4 | int:ATP6V0C | |
| Interaction | TUSC3 interactions | 8.79e-04 | 61 | 62 | 3 | int:TUSC3 | |
| Interaction | SIDT2 interactions | 9.11e-04 | 140 | 62 | 4 | int:SIDT2 | |
| Interaction | GP1BB interactions | 9.65e-04 | 63 | 62 | 3 | int:GP1BB | |
| Interaction | SMCO4 interactions | 1.01e-03 | 64 | 62 | 3 | int:SMCO4 | |
| Interaction | LMBRD2 interactions | 1.06e-03 | 65 | 62 | 3 | int:LMBRD2 | |
| Interaction | CBLIF interactions | 1.09e-03 | 16 | 62 | 2 | int:CBLIF | |
| Interaction | PSCA interactions | 1.09e-03 | 147 | 62 | 4 | int:PSCA | |
| Interaction | ABHD14A interactions | 1.11e-03 | 66 | 62 | 3 | int:ABHD14A | |
| Interaction | MALL interactions | 1.18e-03 | 150 | 62 | 4 | int:MALL | |
| Interaction | EFNA5 interactions | 1.21e-03 | 68 | 62 | 3 | int:EFNA5 | |
| Interaction | MFAP3 interactions | 1.21e-03 | 68 | 62 | 3 | int:MFAP3 | |
| Interaction | TMEM239 interactions | 1.31e-03 | 70 | 62 | 3 | int:TMEM239 | |
| Interaction | EIF2AK3 interactions | 1.33e-03 | 155 | 62 | 4 | int:EIF2AK3 | |
| Interaction | OR10H2 interactions | 1.42e-03 | 72 | 62 | 3 | int:OR10H2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 1.04e-03 | 137 | 66 | 3 | chr9q31 | |
| Cytoband | 16q13 | 1.24e-03 | 36 | 66 | 2 | 16q13 | |
| GeneFamily | Solute carriers | SLC24A5 SLC41A2 SLC7A1 SLC44A1 SLC12A1 SLC12A2 SLC24A4 SLC22A16 SLC24A2 SLC44A2 SLC24A3 | 1.58e-08 | 395 | 53 | 11 | 752 |
| GeneFamily | Opsin receptors | 3.86e-06 | 11 | 53 | 3 | 215 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.30e-05 | 16 | 53 | 3 | 173 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 1.75e-04 | 7 | 53 | 2 | 285 | |
| GeneFamily | Progestin and adipoQ receptor family | 4.56e-04 | 11 | 53 | 2 | 930 | |
| GeneFamily | Rhomboid family | 7.50e-04 | 14 | 53 | 2 | 926 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 1.25e-03 | 18 | 53 | 2 | 812 | |
| GeneFamily | Taste 2 receptors | 5.83e-03 | 39 | 53 | 2 | 1162 | |
| Coexpression | GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN | 8.66e-06 | 200 | 63 | 6 | M5811 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-08 | 192 | 66 | 7 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.86e-08 | 199 | 66 | 7 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.93e-08 | 200 | 66 | 7 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.93e-08 | 200 | 66 | 7 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.93e-08 | 200 | 66 | 7 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.46e-07 | 176 | 66 | 6 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.10e-07 | 192 | 66 | 6 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.36e-07 | 194 | 66 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.77e-07 | 197 | 66 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.91e-07 | 198 | 66 | 6 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-07 | 200 | 66 | 6 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-07 | 200 | 66 | 6 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-07 | 200 | 66 | 6 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-07 | 200 | 66 | 6 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-5|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.87e-06 | 137 | 66 | 5 | a7c76201b8901b2ef7ebbb4dfe0cec0dc4534ef5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.39e-06 | 170 | 66 | 5 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.70e-06 | 183 | 66 | 5 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-06 | 184 | 66 | 5 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 184 | 66 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 184 | 66 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-06 | 184 | 66 | 5 | 4f4aeef3b821a003e857fe4a195124d44b2d7479 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 184 | 66 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.12e-06 | 185 | 66 | 5 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.12e-06 | 185 | 66 | 5 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.34e-06 | 186 | 66 | 5 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.34e-06 | 186 | 66 | 5 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.55e-06 | 187 | 66 | 5 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.55e-06 | 187 | 66 | 5 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 187 | 66 | 5 | a63fa3255ad58f3a73c596df99ce9649fdbaeb39 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.55e-06 | 187 | 66 | 5 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | droplet-Large_Intestine-COLON:P+D|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 187 | 66 | 5 | b1bb5c48258a9d058614d23001899dbe44857a1f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.78e-06 | 188 | 66 | 5 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-06 | 188 | 66 | 5 | bfd3b4f57785596b2bd2c657e0d2d8b0f40ba36d | |
| ToppCell | Neuronal_cells-Schwann_cells|World / Lineage and Cell class | 9.01e-06 | 189 | 66 | 5 | 371cdc92549269e45c23c5a5b3cae9c5d35ee217 | |
| ToppCell | Neuronal_cells|World / Lineage and Cell class | 9.01e-06 | 189 | 66 | 5 | 3948775a0ebd4b32c1623d5487f5581e6e2934d7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.01e-06 | 189 | 66 | 5 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.01e-06 | 189 | 66 | 5 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.24e-06 | 190 | 66 | 5 | 396b7225c2430db3dc55a3d0db70239b71987229 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-06 | 192 | 66 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 9.97e-06 | 193 | 66 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.02e-05 | 194 | 66 | 5 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 194 | 66 | 5 | 715e02e5f3250b1bfdc26b7dfd656ba4e705ea84 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-05 | 194 | 66 | 5 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.10e-05 | 197 | 66 | 5 | a72047b7428c0d4aaf016c1ac23dc30919260fd8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 198 | 66 | 5 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 199 | 66 | 5 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 199 | 66 | 5 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 199 | 66 | 5 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 199 | 66 | 5 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.18e-05 | 200 | 66 | 5 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.41e-05 | 113 | 66 | 4 | 0651fb7a7e1ea84b8365059e5ed85bf6c082da1a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.41e-05 | 113 | 66 | 4 | 0e153efddd061d7510dfc3859cc8b1a7984fa70e | |
| ToppCell | Control-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.05e-05 | 120 | 66 | 4 | 695dab6b01ad2c33cdcaf92bb9996ff2899ef77e | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.12e-05 | 137 | 66 | 4 | ca8fdbe66a854e6283b22179ec9359ea9e86cd8e | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.12e-05 | 137 | 66 | 4 | 5e97480f014f1d9267e8126f1d0e58acd22f36aa | |
| ToppCell | TCGA-Peripheral_Nervous_System|World / Sample_Type by Project: Shred V9 | 6.22e-05 | 144 | 66 | 4 | 3bbadb4b07ffb461d5400a5d69ad3b259f74041e | |
| ToppCell | Control-Myeloid-Dendritic_cells-pDC|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.39e-05 | 145 | 66 | 4 | bab85a72142b6257f7d424e5301f65b6dcdf745d | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-05 | 154 | 66 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-05 | 154 | 66 | 4 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | Entopeduncular|World / BrainAtlas - Mouse McCarroll V32 | 9.35e-05 | 160 | 66 | 4 | 833763c8608de4ee6003b8fb682aa9c83d7dea9b | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.58e-05 | 161 | 66 | 4 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.81e-05 | 162 | 66 | 4 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.81e-05 | 162 | 66 | 4 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.81e-05 | 162 | 66 | 4 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.81e-05 | 162 | 66 | 4 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 1.00e-04 | 163 | 66 | 4 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-04 | 164 | 66 | 4 | 3a4ecc632be003d09b765c992804134348d2278b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.03e-04 | 164 | 66 | 4 | 4b10b78d4d76023c3c5bcd427757218fdd5465ca | |
| ToppCell | Int-URO-Myeloid-tDC|Int-URO / Disease, Lineage and Cell Type | 1.05e-04 | 165 | 66 | 4 | 9803c3db6cdcf925bea7d9c382bf4fd05acf3509 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 166 | 66 | 4 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 167 | 66 | 4 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 167 | 66 | 4 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.15e-04 | 169 | 66 | 4 | e3410ccb3f85811c75694e286115803911169a2f | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-04 | 169 | 66 | 4 | a4f610d07c3ba5537f4497f523669b914f7eddc1 | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 1.21e-04 | 171 | 66 | 4 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-04 | 171 | 66 | 4 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 172 | 66 | 4 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | lymphoid-B_cell-pro-B|B_cell / Lineage, cell class and subclass | 1.24e-04 | 172 | 66 | 4 | da1e2e54f442f5c2032c857c4812e9060f2053cd | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue | 1.24e-04 | 172 | 66 | 4 | 701de463f85aaad3a4b36a0d5fbc416406620089 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 172 | 66 | 4 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 173 | 66 | 4 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 173 | 66 | 4 | 73f858f2c45d19b9ec8d99ac02c91551790f670c | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.26e-04 | 173 | 66 | 4 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 174 | 66 | 4 | 009e88a6c79689a5d88b0af50aa89aa03b33f800 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 174 | 66 | 4 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-04 | 174 | 66 | 4 | 991f7eab69ea3ee1045a4e44ce60a96db13df6d1 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 174 | 66 | 4 | a0a059bb2a64d7011e206db2ebcdf3eb655a925a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 174 | 66 | 4 | e9e4532a474b4b0938a50ff85c9508aca53cd3ae | |
| ToppCell | Substantia_nigra-Macroglia|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.29e-04 | 174 | 66 | 4 | 7e7f7ca9a413ec255e54621800a279c771b9e6b7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 174 | 66 | 4 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 174 | 66 | 4 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| Computational | Ion channels. | 6.68e-05 | 27 | 32 | 3 | MODULE_214 | |
| Computational | Genes in the cancer module 27. | 5.44e-04 | 355 | 32 | 6 | MODULE_27 | |
| Computational | Ion channels. | 1.15e-03 | 70 | 32 | 3 | MODULE_316 | |
| Computational | Genes in the cancer module 301. | 1.17e-03 | 158 | 32 | 4 | MODULE_301 | |
| Computational | Genes in the cancer module 238. | 1.35e-03 | 164 | 32 | 4 | MODULE_238 | |
| Drug | rocuronium | 1.97e-08 | 11 | 65 | 4 | ctd:C061870 | |
| Drug | Vecuronium Bromide | 2.94e-08 | 12 | 65 | 4 | ctd:D014673 | |
| Drug | mivacurium | 7.71e-07 | 7 | 65 | 3 | ctd:C049430 | |
| Drug | Atracurium | 7.71e-07 | 7 | 65 | 3 | ctd:D001279 | |
| Drug | Rubidium chromate | 2.24e-06 | 74 | 65 | 5 | CID000061605 | |
| Drug | muscarine | 3.50e-06 | 144 | 65 | 6 | CID000009308 | |
| Drug | cytisine | 3.60e-06 | 11 | 65 | 3 | ctd:C004712 | |
| Drug | Pancuronium | 3.60e-06 | 11 | 65 | 3 | ctd:D010197 | |
| Drug | Varenicline | 7.90e-06 | 14 | 65 | 3 | ctd:D000068580 | |
| Drug | KB-R7943 | 9.84e-06 | 47 | 65 | 4 | CID004534086 | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 2.29e-05 | 200 | 65 | 6 | 4364_DN | |
| Drug | Alcuronium | 2.40e-05 | 3 | 65 | 2 | ctd:D000443 | |
| Drug | bromide;iodide | 2.40e-05 | 3 | 65 | 2 | CID009907214 | |
| Drug | 1,2-bis-N-cytisinylethane | 2.40e-05 | 3 | 65 | 2 | ctd:C482518 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 2.45e-05 | 20 | 65 | 3 | CID000001962 | |
| Drug | 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid | 2.70e-05 | 206 | 65 | 6 | CID000040600 | |
| Drug | methylglucamine | 2.98e-05 | 62 | 65 | 4 | CID000004049 | |
| Drug | amiloride | 3.18e-05 | 315 | 65 | 7 | CID000016230 | |
| Drug | AR-R17779 | 3.29e-05 | 22 | 65 | 3 | CID005310971 | |
| Drug | Ultracet | 3.38e-05 | 64 | 65 | 4 | CID000005523 | |
| Drug | alpha-conotoxin ImI | 3.78e-05 | 23 | 65 | 3 | CID000133011 | |
| Drug | ABT-418 | 3.78e-05 | 23 | 65 | 3 | CID000119380 | |
| Drug | anabaseine | 4.31e-05 | 24 | 65 | 3 | CID000018985 | |
| Drug | Anabasine | 4.80e-05 | 4 | 65 | 2 | ctd:D000691 | |
| Drug | 2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane | 4.80e-05 | 4 | 65 | 2 | ctd:C569671 | |
| Drug | alpha-conotoxin MII | 4.80e-05 | 4 | 65 | 2 | ctd:C098872 | |
| Drug | curarine | 5.51e-05 | 26 | 65 | 3 | CID000198004 | |
| Drug | Dopamine | 6.33e-05 | 240 | 65 | 6 | ctd:D004298 | |
| Drug | hemicholinium-3 | 7.36e-05 | 78 | 65 | 4 | CID000003585 | |
| Drug | AC1L1BQX | 7.74e-05 | 79 | 65 | 4 | CID000001565 | |
| Drug | Quinethazone | 7.98e-05 | 5 | 65 | 2 | DB01325 | |
| Drug | N-(1,2,3,4-tetrahydro-1-naphthyl)-4-nitroaniline | 7.98e-05 | 5 | 65 | 2 | ctd:C524978 | |
| Drug | cisatracurium | 7.98e-05 | 5 | 65 | 2 | ctd:C101584 | |
| Drug | Bumetanide | 7.98e-05 | 5 | 65 | 2 | DB00887 | |
| Drug | Pyridines | 1.19e-04 | 6 | 65 | 2 | ctd:D011725 | |
| Drug | decamethonium | 1.19e-04 | 6 | 65 | 2 | ctd:C033019 | |
| Drug | 1-Propanol | 1.19e-04 | 6 | 65 | 2 | ctd:D000433 | |
| Drug | Potassium Chloride | 1.19e-04 | 6 | 65 | 2 | DB00761 | |
| Drug | potassium | CHRNA6 SLC7A1 PLLP SLC12A1 SLC12A2 HTR3A SLC24A4 SLC24A2 KCNK5 SLC24A3 CHRNB2 | 1.21e-04 | 1008 | 65 | 11 | CID000000813 |
| Drug | GTS-21 | 1.25e-04 | 34 | 65 | 3 | CID005310985 | |
| Drug | atracurium | 1.36e-04 | 35 | 65 | 3 | CID000047319 | |
| Drug | AC1NDT8A | 1.61e-04 | 37 | 65 | 3 | CID004631218 | |
| Drug | EPTC | 1.67e-04 | 7 | 65 | 2 | ctd:C036251 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.73e-04 | 182 | 65 | 5 | 5511_UP | |
| Drug | 2-Br | 1.89e-04 | 39 | 65 | 3 | CID000007244 | |
| Drug | LIGA20 | 1.89e-04 | 39 | 65 | 3 | CID006441213 | |
| Drug | Dimethylphenylpiperazinium Iodide | 2.22e-04 | 8 | 65 | 2 | ctd:D004246 | |
| Drug | epibatidine | 2.22e-04 | 8 | 65 | 2 | ctd:C082748 | |
| Drug | QX-222 | 2.35e-04 | 42 | 65 | 3 | CID000005014 | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | 2.44e-04 | 196 | 65 | 5 | 1289_UP | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; HL60; HT_HG-U133A | 2.50e-04 | 197 | 65 | 5 | 3043_DN | |
| Drug | genistein; Down 200; 1uM; MCF7; HG-U133A | 2.62e-04 | 199 | 65 | 5 | 267_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; HL60; HG-U133A | 2.62e-04 | 199 | 65 | 5 | 2023_UP | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; HL60; HG-U133A | 2.62e-04 | 199 | 65 | 5 | 1964_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 199 | 65 | 5 | 3430_DN | |
| Disease | blue cone monochromacy (implicated_via_orthology) | 4.07e-08 | 4 | 65 | 3 | DOID:0050679 (implicated_via_orthology) | |
| Disease | cutaneous melanoma, hair color | 1.09e-05 | 62 | 65 | 4 | EFO_0000389, EFO_0003924 | |
| Disease | mastiha supplement exposure measurement, blood glutathione peroxidase measurement | 4.76e-05 | 5 | 65 | 2 | EFO_0600067, EFO_0600071 | |
| Disease | verbal memory measurement | 9.96e-05 | 7 | 65 | 2 | EFO_0009591 | |
| Disease | attempted suicide, mood disorder | 1.33e-04 | 8 | 65 | 2 | EFO_0004247, EFO_0004321 | |
| Disease | skin pigmentation measurement | 2.42e-04 | 137 | 65 | 4 | EFO_0007009 | |
| Disease | pro‐interleukin‐16 measurement | 2.59e-04 | 11 | 65 | 2 | EFO_0010629 | |
| Disease | Withdrawal Symptoms | 2.89e-04 | 58 | 65 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.89e-04 | 58 | 65 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.89e-04 | 58 | 65 | 3 | C0038587 | |
| Disease | epilepsy (implicated_via_orthology) | 4.67e-04 | 163 | 65 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 5.62e-04 | 16 | 65 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism | 6.36e-04 | 17 | 65 | 2 | EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140 | |
| Disease | migraine disorder, systolic blood pressure | 7.15e-04 | 18 | 65 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | nose morphology measurement | 7.99e-04 | 329 | 65 | 5 | EFO_0007843 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 9.14e-04 | 195 | 65 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | serum iron measurement | 9.16e-04 | 86 | 65 | 3 | EFO_0006332 | |
| Disease | migraine disorder, Headache | 9.16e-04 | 86 | 65 | 3 | HP_0002315, MONDO_0005277 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 1.22e-03 | 95 | 65 | 3 | EFO_0803331 | |
| Disease | upper face morphology measurement | 1.30e-03 | 97 | 65 | 3 | EFO_0010949 | |
| Disease | migraine disorder, diastolic blood pressure | 1.39e-03 | 25 | 65 | 2 | EFO_0006336, MONDO_0005277 | |
| Disease | executive function measurement | 1.44e-03 | 376 | 65 | 5 | EFO_0009332 | |
| Disease | lean body mass | 1.50e-03 | 379 | 65 | 5 | EFO_0004995 | |
| Disease | lysophosphatidylethanolamine 18:2 measurement | 1.50e-03 | 26 | 65 | 2 | EFO_0010369 | |
| Disease | ergothioneine measurement | 1.50e-03 | 26 | 65 | 2 | EFO_0021163 | |
| Disease | R-6-hydroxywarfarin to R-warfarin ratio measurement | 1.67e-03 | 106 | 65 | 3 | EFO_0803333 | |
| Disease | body weight | SLC7A1 SLC12A2 SLC24A4 SLC24A2 DSPP SLC44A2 ADGRV1 GPR151 GPRC5B | 1.71e-03 | 1261 | 65 | 9 | EFO_0004338 |
| Disease | Cone-Rod Dystrophy 2 | 1.87e-03 | 29 | 65 | 2 | C3489532 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WKYVAMVVDRLFLWV | 451 | P30926 | |
| LMIAAAWVLSFVLWA | 151 | P08173 | |
| VTLVVNRWWSQYLCM | 86 | Q8NFU1 | |
| MRWIISEIYAVWKIF | 136 | Q8N7X0 | |
| VLAYSITLVMLWSIW | 461 | P46098 | |
| SWMLIQSVNFWYVLV | 5986 | Q8WXG9 | |
| MDTYSFTTVKLLWIW | 96 | Q4W4Y0 | |
| MKIITYFCIWAVAWA | 1 | Q9NZW4 | |
| WLSLFTVMAYKLTWV | 441 | O43155 | |
| TLWIAVFSYIMVWLV | 461 | Q8NFF2 | |
| WVYHLTSVWMIFVVI | 51 | P0DN78 | |
| YGWVMFVAVFLWLVT | 66 | Q9Y342 | |
| LDFWRMIWEYSVLII | 111 | Q9Y2R2 | |
| WVYHLTSVWMIFVVI | 51 | P0DN77 | |
| AVVMLYWWHQSTVYV | 281 | Q6TCH7 | |
| GWLTLMVAYLVHYVW | 231 | A6NJW4 | |
| RWLVWIMASVGTIYV | 136 | Q8IY49 | |
| FSWSYILGWVAVLMT | 136 | P55344 | |
| PMAVTIFCYWRFVWI | 191 | O15552 | |
| IFCYWRFVWIMLSQP | 196 | O15552 | |
| IQWWNAVFIMLLIGI | 216 | Q5XG99 | |
| AWLSLFVNWKVSMFV | 236 | O95279 | |
| YVWAQLNRDMIVSFW | 131 | Q9BUN8 | |
| MYVWPCAVVLAQYLW | 1 | Q86XA0 | |
| NYTIWSVLVAIWTVA | 151 | Q8TDV0 | |
| VSWWESLVLVLMYLI | 236 | Q9HC58 | |
| WVYHLTSVWMIFVVI | 51 | P04001 | |
| FLSVLIWVAWMTMYL | 241 | Q9NZH0 | |
| TSVAIWVVWIVMYTY | 251 | Q9NQ84 | |
| LVYFFGMASSIWWVI | 321 | Q13467 | |
| WKYVAMVVDRVFLWV | 456 | Q15825 | |
| VTVWFMVIYVTLALW | 521 | Q96PB1 | |
| MWCIVLFSLLAWVYA | 1 | P09871 | |
| GFLIFIWYWSMRLQA | 651 | Q9Y653 | |
| TFFALVLFWVYWIMT | 341 | Q8WWI5 | |
| VLFWVYWIMTLLFLG | 346 | Q8WWI5 | |
| LQYMWWYHVVGLIWI | 381 | Q8WWI5 | |
| SWYWIIIGLVIAMAM | 231 | Q8IWA5 | |
| VAWSISFYPQVIMNW | 136 | O60931 | |
| LSVIVLFSYMQWVWG | 246 | Q96G97 | |
| AYMLVCMQWADLLWA | 286 | Q9Y5Q0 | |
| IIESWMTVQNLWIYL | 1621 | Q8TE73 | |
| VLYVQMAAWSWIIGC | 171 | Q8NGV5 | |
| IGLLWVMLFLWYATV | 56 | P59542 | |
| LKQIFLSVFWQMRYW | 286 | P0DTE0 | |
| ALVYAILVIWTWSML | 206 | Q6ZUK4 | |
| IIFVWAFTSLYCMLW | 146 | P34981 | |
| TVLRNLTEMWYWIFL | 26 | Q5T4T1 | |
| IMPIFWRVVYWTSQF | 106 | Q68DH5 | |
| MLIIFFLDNVIMWWE | 251 | Q9UI40 | |
| QDQSLWWIFVAMYTV | 366 | P58872 | |
| GYLVRTWWLYQMILS | 261 | Q86VW1 | |
| DFWRMIWEYNVVIIV | 116 | Q05209 | |
| FVINWWAAVITYVIE | 621 | Q13621 | |
| LQVFTLLWIADWMVH | 511 | Q96JW4 | |
| WKYVAMVIDRLFLWI | 451 | P17787 | |
| WFQLKVWSMAVVSIL | 16 | Q8WTT0 | |
| GWVMFVAVFYWVLTV | 71 | Q8IZV2 | |
| WWLNTMVFPVMYNLI | 36 | Q8IV77 | |
| WLMNWFSVLAGIIIF | 21 | P23942 | |
| WVRFAVWMLIGFIIY | 586 | P30825 | |
| MQAARVDYIAPWWVV | 1 | Q9BSA4 | |
| VMFVINWWAALLTYV | 726 | P55011 | |
| YFHKLQVFMWWILEL | 926 | Q9H5I5 | |
| WDWLIAYNVFVITMK | 1346 | Q9H5I5 | |
| SAIWISAFTYILVWM | 341 | Q71RS6 | |
| ACWIILMVFSIWLYR | 906 | Q9Y6N7 | |
| FVSLVWAIVVMQIWL | 356 | Q9H330 | |
| LKAFWWLVVAYTMLV | 626 | Q92508 | |
| LWNQLVVPVLFMVFW | 221 | Q96MT1 | |
| FSQPEVQLWALWAMY | 681 | Q6WRX3 | |
| WVWTVIFLVPYLQMF | 101 | Q8N6I4 | |
| VILNWMRYTQTVDIW | 196 | P53778 |